ClinicalTrials.govpublic full text
FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
metastatic pancreatic adenocarcinoma, recurrent pancreatic carcinoma, stage iv pancreatic cancer ajcc v6 and v7, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829122
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.